Wielsbeke, Belgium

Carlo Boutton

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 162(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: Carlo Boutton: A Renowned Inventor and Patent Holder

Introduction:

Introducing Carlo Boutton, an innovative inventor with a remarkable portfolio of patents in the field of biotechnology. Hailing from Wielsbeke, Belgium, Boutton's contributions to scientific advancements have garnered widespread recognition. This article explores his latest patents, career highlights, notable collaborations, and the significance of his work.

Latest Patents:

Carlo Boutton's prolific career has resulted in the successful acquisition of an impressive 27 patents. Among his latest inventions, two stand out as noteworthy contributions to the field of biopharmaceuticals:

1. Immunoglobulin Variable Domains - VH domain:

This patent introduces a novel approach in immunoglobulin engineering. Specifically, the patent showcases modifications in the VH domain, primarily focusing on specific amino acid residues at positions 112 and 89. Additionally, the patent incorporates a C-terminal extension, denoted as (X)n, wherein n signifies the number of extensions ranging from 1 to 10. These inventive modifications pave the way for enhanced therapeutic possibilities in various immune-related diseases.

2. CTLA4 Binders:

Boutton's second recent patent revolves around the development of molecules capable of binding to CTLA4 or human serum albumin. These molecules, designed as ISVDs (Intracellular Single-Variable Domains) and Nanobodies, possess the unique attribute of reducing the incidence of binding by pre-existing antibodies within a subject's body. This breakthrough innovation holds tremendous potential for augmenting immune responses, treating cancer, and combating infectious diseases more effectively.

Career Highlights:

Throughout his illustrious career, Carlo Boutton has held prominent positions in renowned companies, contributing his expertise and inventive prowess to their successes. Notable highlights include his tenure at Ablynx N.V. and Merck Sharp & Dohme Corporation. In these roles, Boutton played an instrumental part in the development and patenting of innovative biotechnological solutions, garnering widespread recognition for his scientific contributions.

Collaborations:

Within the scientific community, collaboration plays a pivotal role in pushing the boundaries of innovation. Carlo Boutton has had the privilege of working alongside esteemed professionals, and two of his valued coworkers are Marie-Ange Buyse and Bruno Dombrecht. These collaborative efforts fostered an environment where creative ideas flourished, leading to groundbreaking inventions and patents.

Conclusion:

Carlo Boutton's dedication to biotechnology and his exceptional inventiveness have made him a trailblazer in the field. With an impressive portfolio of 27 patents, his recent contributions in immunoglobulin engineering and the development of CTLA4 binders exhibit the potential to revolutionize therapeutics and improve patient outcomes. Collaborating with industry-leading companies and esteemed coworkers further solidifies his standing as a pioneering inventor within the scientific community. As his career progresses, the world eagerly awaits the innovative solutions Carlo Boutton will bring forth in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…